Abstract
Amniotic fluid embolism (AFE) is a rare and severe obstetric emergency and a significant cause of maternal mortality in developed countries and its incidence varies according to different studies. Presently, advances in the understanding of this pathology continue to be slowed down for the absence of generally accepted diagnostic criteria, the clinical analogies of this entity to other types of acute dangerous maternal illnesses and the presence of a wide range of disease severity. The aim of this review has been to evaluate the incidence of AFE, the role of possible risk factors, the clinical presentation (signs and symptoms) and outcome. Secondly the authors reviewed the management of these very difficult patients, including treatments and interventions in order to extrapolate sharable recommendations for the management of these complicated patients.
Keywords: Amniotic fluid embolism, incidence, risk factors, management and treatment, scientific evidence.
Current Pharmaceutical Biotechnology
Title:Amniotic Fluid Embolism: What Level of Scientific Evidence can be Drawn? A Systematic Review
Volume: 14 Issue: 14
Author(s): Paola Frati, Zeno Foldes-Papp, Simona Zaami and Francesco P. Busardo
Affiliation:
Keywords: Amniotic fluid embolism, incidence, risk factors, management and treatment, scientific evidence.
Abstract: Amniotic fluid embolism (AFE) is a rare and severe obstetric emergency and a significant cause of maternal mortality in developed countries and its incidence varies according to different studies. Presently, advances in the understanding of this pathology continue to be slowed down for the absence of generally accepted diagnostic criteria, the clinical analogies of this entity to other types of acute dangerous maternal illnesses and the presence of a wide range of disease severity. The aim of this review has been to evaluate the incidence of AFE, the role of possible risk factors, the clinical presentation (signs and symptoms) and outcome. Secondly the authors reviewed the management of these very difficult patients, including treatments and interventions in order to extrapolate sharable recommendations for the management of these complicated patients.
Export Options
About this article
Cite this article as:
Frati Paola, Foldes-Papp Zeno, Zaami Simona and Busardo P. Francesco, Amniotic Fluid Embolism: What Level of Scientific Evidence can be Drawn? A Systematic Review, Current Pharmaceutical Biotechnology 2013; 14 (14) . https://dx.doi.org/10.2174/1389201015666140430101639
DOI https://dx.doi.org/10.2174/1389201015666140430101639 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Male Pelvic Pain: Beyond Urology and Chronic Prostatitis
Current Rheumatology Reviews [6]-gingerol as a Cancer Chemopreventive Agent: A Review of Its Activity on Different Steps of the Metastatic Process
Mini-Reviews in Medicinal Chemistry Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism Subject Index to Volume 2
Current Vascular Pharmacology Isoniazid Induced Convulsions at Therapeutic Dose in an Alcoholic and Smoker Patient
Current Drug Safety Mechanisms of Cardiovascular Changes in an Experimental Model of Syndrome X and Pharmacological Intervention on the Renin-Angiotensin- System
Current Vascular Pharmacology Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta- Analysis of Randomized Trials
Current Vascular Pharmacology Urocortins: Take Them to Heart
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Biotechnological Approaches for the Treatment of Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives
Current Clinical Pharmacology Infection and Hemodialysis Access: An Updated Review.
Infectious Disorders - Drug Targets Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine
Current Drug Therapy Utility of the Electrocardiogram in Drug Overdose and Poisoning: Theoretical Considerations and Clinical Implications
Current Cardiology Reviews The Pursuit of Differentiated Ligands for the Glucocorticoid Receptor
Current Topics in Medicinal Chemistry Current Concepts in Gastric Motility in Diabetes Mellitus
Current Diabetes Reviews Discovery and Development of Antifungal Compounds
Current Medicinal Chemistry - Anti-Infective Agents Pharmacological Treatment of Hypertension in Pregnancy
Current Pharmaceutical Design Histamine and Histamine Receptor Antagonists in Cancer Biology
Inflammation & Allergy - Drug Targets (Discontinued) Treatment of Severe Cases of Pandemic (H1N1) 2009 Influenza: Review of Antivirals and Adjuvant Therapy
Recent Patents on Anti-Infective Drug Discovery